Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ANAB

AnaptysBio Inc

May 29 • 04:00PM ET

55.67

-1.35 -2.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: APGE KYMR RYTM NUVL BMRN INCY KRYS VKTX AXSM NBIX

| Held by: VTI XBI IWM VXF IBB BRES IWO FYC VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.08	Insider Own	6.43%	Shs Outstand	29.03M	Perf Week	-7.85%
Market Cap	1.62B	Forward P/E	-	EPS next Y	-2.34	Insider Trans	-9.42%	Shs Float	27.23M	Perf Month	-10.70%
Enterprise Value	1.61B	PEG	-	EPS next Q	-0.27	Inst Own	100.70%	Short Float	17.61%	Perf Quarter	51.71%
Income	-26.79M	P/S	6.97	EPS this Y	-563.84%	Inst Trans	2.36%	Short Ratio	5.76	Perf Half Y	101.25%
Sales	232.39M	P/B	126.78	EPS next Y	-15.11%	ROA	-7.13%	Short Interest	4.80M	Perf YTD	72.27%
Book/sh	0.44	P/C	5.66	EPS next 5Y	-	ROE	-114.55%	52W High	72.36 -23.07%	Perf Year	270.20%
Cash/sh	9.84	P/FCF	367.36	EPS past 3/5Y	53.48% 8.82%	ROIC	-9.30%	52W Low	11.40 388.23%	Perf 3Y	347.81%
Dividend Est.	-	EV/EBITDA	37.26	Sales past 3/5Y	183.58% 25.62%	Gross Margin	98.96%	Volatility	4.49% 6.31%	Perf 5Y	249.88%
Dividend TTM	-	EV/Sales	6.93	EPS Y/Y TTM	82.33%	Oper. Margin	17.56%	ATR (14)	3.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.58	Sales Y/Y TTM	107.73%	Profit Margin	-11.53%	RSI (14)	42.27	Recom	1.09
Dividend Gr. 3/5Y	- -	Current Ratio	7.58	EPS Q/Q	-43.62%	SMA20	-11.48%	Beta	0.88	Target Price	73.18
Payout	-	Debt/Eq	21.75	Sales Q/Q	-7.98%	SMA50	4.04%	Rel Volume	0.60	Prev Close	57.02
Employees	104	LT Debt/Eq	21.59	Earnings	May 12 AMC	SMA200	67.59%	Avg Volume	833.15K	Price	55.67
IPO	Jan 26, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-185.89% 35.48%	Trades		Volume	501,165	Change	-2.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)